Alligator Bioscience and SARomics Signs Collaboration Agreement
Alligator Bioscience AB and SARomics AB have entered into a strategic collaboration agreement. Alligator Bioscience uses its proprietary FIND technology to develop new and optimize existing therapeutic and diagnostic proteins, and SARomics specializes in finding and exploring structure-activity-relationships, SAR, in both small molecule-based and protein-based drug discovery projects.
Alligator Bioscience intends to offer the services performed at SARomics as an integral part of Alligator Bioscience and wishes to apply SARomics' technology and know-how in conjunction with its technology platform, in order to decrease the project time for internal and external projects.
For further information please contact:
Ann-Christin Malmborg,
VP Business Development of Alligator Bioscience
Tel: +46 46 286 42 95
Email: anm@alligatorbioscience.com
Or visit: www.alligatorbioscience.com
Alligator Bioscience AB is a biotechnology company that focuses on discovery and development of early protein drug candidates, independently and in partnership, within inflammation and cancer. Since 2001, the FIND® (Fragment INduced Diversity) technology platform has been validated by successfully...